Italy
· Delayed Price · Currency is EUR Madrigal Pharmaceuticals Statistics
Total Valuation
BIT:1MDGL has a market cap or net worth of EUR 6.01 billion. The enterprise value is 5.35 billion.
| Market Cap | 6.01B |
| Enterprise Value | 5.35B |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.87% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.45 |
| PB Ratio | 9.13 |
| P/TBV Ratio | 9.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.78 |
| EV / Sales | 18.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.60 |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.91 |
| Quick Ratio | 5.41 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.30 |
| Interest Coverage | -30.09 |
Financial Efficiency
Return on equity (ROE) is -50.16% and return on invested capital (ROIC) is -29.54%.
| Return on Equity (ROE) | -50.16% |
| Return on Assets (ROA) | -25.56% |
| Return on Invested Capital (ROIC) | -29.54% |
| Return on Capital Employed (ROCE) | -51.26% |
| Revenue Per Employee | 556,142 |
| Profits Per Employee | -686,171 |
| Employee Count | 528 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.85 |
Income Statement
In the last 12 months, BIT:1MDGL had revenue of EUR 293.64 million and -362.30 million in losses. Loss per share was -16.62.
| Revenue | 293.64M |
| Gross Profit | 283.70M |
| Operating Income | -393.35M |
| Pretax Income | -362.30M |
| Net Income | -362.30M |
| EBITDA | -392.14M |
| EBIT | -393.35M |
| Loss Per Share | -16.62 |
Balance Sheet
The company has 780.01 million in cash and 110.81 million in debt, giving a net cash position of 669.19 million.
| Cash & Cash Equivalents | 780.01M |
| Total Debt | 110.81M |
| Net Cash | 669.19M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 657.48M |
| Book Value Per Share | 29.63 |
| Working Capital | 759.35M |
Cash Flow
In the last 12 months, operating cash flow was -365.74 million and capital expenditures -1.02 million, giving a free cash flow of -366.76 million.
| Operating Cash Flow | -365.74M |
| Capital Expenditures | -1.02M |
| Free Cash Flow | -366.76M |
| FCF Per Share | n/a |
Margins
Gross margin is 96.61%, with operating and profit margins of -133.95% and -123.38%.
| Gross Margin | 96.61% |
| Operating Margin | -133.95% |
| Pretax Margin | -123.38% |
| Profit Margin | -123.38% |
| EBITDA Margin | -133.54% |
| EBIT Margin | -133.95% |
| FCF Margin | n/a |
Dividends & Yields
BIT:1MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.87% |
| Shareholder Yield | -13.87% |
| Earnings Yield | -6.03% |
| FCF Yield | -6.11% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1MDGL has an Altman Z-Score of 9.76.
| Altman Z-Score | 9.76 |
| Piotroski F-Score | n/a |